CRISPR upped to outperform by Evercore on upcoming data
Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.
Evercore ISI Keeps Their Buy Rating on Vertiv Holdings (VRT)
In a report released yesterday, Amit Daryanani from Evercore ISI maintained a Buy rating on Vertiv Holdings (VRT – Research Report), with a ...
Modern Healthcare2d
VillageMD taps advisers as Walgreens pursues exit plan
Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...
Evercore ISI maintains Adobe stock Outperform with $650 target
Evercore ISI reiterated its Outperform rating on Adobe stock (NASDAQ:ADBE), maintaining a $650.00 price target for the $199 billion software giant. According to InvestingPro analysis, Adobe is ...
Evercore ISI Pounds the Table on Nvidia (NVDA) Stock Ahead of Earnings
Wall Street investment bank Evercore ISI (EVR) is pounding the table on Nvidia (NVDA) stock ahead of the chipmaker’s upcoming ...